Antidiabetic Agents
Miscellaneous

Brand/Generic Name Dosage/Strength Status Restrictions Notes Relative Cost
Bydureon
exenatide microspheres
2 mg suspension, extended rel recon   nonform.gif (625 bytes)

priorauth.gif (377 bytes) ql.gif

$$$
Byetta
exenatide
10 mcg/0.04 mL Pen Injector   nonform.gif (625 bytes)

priorauth.gif (377 bytes) ql.gif

NOTES_restrict.gif (377 bytes)

Not Applicable
Byetta
exenatide
5 mcg/0.02 mL Pen Injector   nonform.gif (625 bytes)

priorauth.gif (377 bytes) ql.gif

NOTES_restrict.gif (377 bytes)

Not Applicable
Cycloset
bromocriptine
0.8 mg tablet   nonform.gif (625 bytes)

ql.gif

Not Applicable
Invokana
canagliflozin
100 mg tablet; 300 mg tablet   nonform.gif (625 bytes)

st.gif

Not Applicable
Symlin
pramlintide
600 mcg/mL Solution   nonform.gif (625 bytes)

priorauth.gif (377 bytes) ql.gif

NOTES_restrict.gif (377 bytes)

Not Applicable
SymlinPen 120
pramlintide
2,700 mcg/2.7 mL Pen Injector   nonform.gif (625 bytes)

priorauth.gif (377 bytes) ql.gif

NOTES_restrict.gif (377 bytes)

Not Applicable
SymlinPen 60
pramlintide
1,500 mcg/1.5 mL Pen Injector   nonform.gif (625 bytes)

priorauth.gif (377 bytes) ql.gif

NOTES_restrict.gif (377 bytes)

Not Applicable
Victoza
liraglutide
0.6 mg/0.1 mL (18 mg/3 mL) Pen Injector   nonform.gif (625 bytes)

priorauth.gif (377 bytes) ql.gif

Not Applicable
WelChol
colesevelam
3.75 gram Powder in Packet   nonform.gif (625 bytes)  

Not Applicable
WelChol
colesevelam
625 mg tablet   nonform.gif (625 bytes)  

Not Applicable

Key for Product(s) Listed Above
Formulary Prior Authorization (PA may not be required for some benefit plans) Non-Formulary
(Third tier coverage applies for selected plans)
Not Reimbursed
Quantity Limit Not available through mail order as 90-day supply* Step Therapy Generic Available. Brand name medication may be covered at a higher member cost or may not be covered for certain plans.
Notes $Relative cost compared to others in category Specialty distribution for selected plans (Fourth or fifth tier coverage applied for selected plans)

© 2002 Managed Markets Insight and Technology, LLC. All Rights Reserved